Mehra and Subramanian discussed preclinical safety studies with the gene therapy SLS-004 and plans for future research.
Krishna Subramanian, PhD
Advertisement
Articles by Krishna Subramanian, PhD
Mehra and Subramanian discussed preclinical research with the investigational gene therapy SLS-004.
Advertisement
Latest Updated Articles
Raj Mehra, PhD, and Krishna Subramanian, PhD, on Striving For Disease-Modifying Therapies in Parkinson DiseasePublished: February 3rd 2023 | Updated:
